FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193402490> ?p ?o ?g. }

• W3193402490 abstract "Empagliflozin and metformin are widely used for the treatment of type 2 diabetes. These drugs showed marked anti-inflammatory effects in different animal models via enhancing AMPK activity. Yet, the protective anti-inflammatory effects of their combination against ulcerative colitis have not been previously investigated. The current study aimed to explore the potential of empagliflozin/metformin combination to mitigate the DSS-induced rat colitis model. The modulating effects of empagliflozin and metformin on the AMPK/mTOR/NLRP3 axis and T cell polarization were delineated. In this study, distal colons were examined for macroscopic and microscopic pathological alterations. ELISA, qRT-PCR, and immunohistochemistry techniques were applied to detect proteins and cytokines involved in AMPK/mTOR/NLRP3 axis and T Cell polarization. Oral administration of empagliflozin (10 mg/kg/day) and metformin (200 mg/kg/day) combination alleviated colitis as revealed by the reduced disease activity index, macroscopic damage index, colon weight/length ratio, and histopathologic scoring values. Interestingly, empagliflozin/metformin combination significantly enhanced AMPK phosphorylation and depressed mTOR and NLRP3 expression leading to a subsequent reduction in caspase-1 cleavage and inhibition of several inflammatory cytokines, including IL-1β, and IL-18. Reduced mTOR expression and reduced IL-6 levels led to a reduction in Th17 cell polarization and maintenance. Together, the current study reveals that the protective effects of empagliflozin and metformin against DSS-induced colitis are fundamentally mediated via enhancing AMPK phosphorylation. Since adult humans with diabetes mellitus are at greater risk for developing inflammatory bowel diseases, clinical application of empagliflozin/metformin combination represents a novel therapeutic approach for treating diabetic patients with ulcerative colitis." @default.
• W3193402490 created "2021-08-30" @default.
• W3193402490 creator A5007832254 @default.
• W3193402490 creator A5015323959 @default.
• W3193402490 creator A5033515900 @default.
• W3193402490 creator A5036904050 @default.
• W3193402490 creator A5040956118 @default.
• W3193402490 creator A5050059268 @default.
• W3193402490 creator A5064062758 @default.
• W3193402490 creator A5066619473 @default.
• W3193402490 creator A5068572641 @default.
• W3193402490 creator A5069644796 @default.
• W3193402490 creator A5089855305 @default.
• W3193402490 creator A5091501350 @default.
• W3193402490 date "2021-08-16" @default.
• W3193402490 modified "2023-10-14" @default.
• W3193402490 title "Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis" @default.
• W3193402490 cites W185214937 @default.
• W3193402490 cites W1895653898 @default.
• W3193402490 cites W1916611915 @default.
• W3193402490 cites W1980898941 @default.
• W3193402490 cites W1998771362 @default.
• W3193402490 cites W2025639892 @default.
• W3193402490 cites W2056721231 @default.
• W3193402490 cites W2057218469 @default.
• W3193402490 cites W2085281012 @default.
• W3193402490 cites W2121757875 @default.
• W3193402490 cites W2151422820 @default.
• W3193402490 cites W2168400313 @default.
• W3193402490 cites W2212226399 @default.
• W3193402490 cites W2330707041 @default.
• W3193402490 cites W2434638516 @default.
• W3193402490 cites W2525729089 @default.
• W3193402490 cites W2580583036 @default.
• W3193402490 cites W2593816418 @default.
• W3193402490 cites W2598879155 @default.
• W3193402490 cites W2743010525 @default.
• W3193402490 cites W2749836129 @default.
• W3193402490 cites W2755548020 @default.
• W3193402490 cites W2769466337 @default.
• W3193402490 cites W2777514005 @default.
• W3193402490 cites W2786187679 @default.
• W3193402490 cites W2793230973 @default.
• W3193402490 cites W2883673004 @default.
• W3193402490 cites W2891612290 @default.
• W3193402490 cites W2900875627 @default.
• W3193402490 cites W2907794290 @default.
• W3193402490 cites W2911569271 @default.
• W3193402490 cites W2919081348 @default.
• W3193402490 cites W2923199598 @default.
• W3193402490 cites W2954782052 @default.
• W3193402490 cites W2957836220 @default.
• W3193402490 cites W2963113448 @default.
• W3193402490 cites W2968124120 @default.
• W3193402490 cites W2969997661 @default.
• W3193402490 cites W2977873911 @default.
• W3193402490 cites W2978239310 @default.
• W3193402490 cites W2979652934 @default.
• W3193402490 cites W2985976802 @default.
• W3193402490 cites W2986108390 @default.
• W3193402490 cites W2988212132 @default.
• W3193402490 cites W2989603136 @default.
• W3193402490 cites W2991094870 @default.
• W3193402490 cites W3004297403 @default.
• W3193402490 cites W3021829885 @default.
• W3193402490 cites W3028762760 @default.
• W3193402490 cites W3033829306 @default.
• W3193402490 cites W3037800601 @default.
• W3193402490 cites W3040863842 @default.
• W3193402490 cites W3043111807 @default.
• W3193402490 cites W3093559869 @default.
• W3193402490 cites W3111088465 @default.
• W3193402490 cites W3125661280 @default.
• W3193402490 cites W3128031713 @default.
• W3193402490 cites W3143657138 @default.
• W3193402490 cites W3150108792 @default.
• W3193402490 cites W3163302553 @default.
• W3193402490 cites W3169937201 @default.
• W3193402490 cites W4211138554 @default.
• W3193402490 doi "https://doi.org/10.3389/fphar.2021.719984" @default.
• W3193402490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8417441" @default.
• W3193402490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34489707" @default.
• W3193402490 hasPublicationYear "2021" @default.
• W3193402490 type Work @default.
• W3193402490 sameAs 3193402490 @default.
• W3193402490 citedByCount "31" @default.
• W3193402490 countsByYear W31934024902022 @default.
• W3193402490 countsByYear W31934024902023 @default.
• W3193402490 crossrefType "journal-article" @default.
• W3193402490 hasAuthorship W3193402490A5007832254 @default.
• W3193402490 hasAuthorship W3193402490A5015323959 @default.
• W3193402490 hasAuthorship W3193402490A5033515900 @default.
• W3193402490 hasAuthorship W3193402490A5036904050 @default.
• W3193402490 hasAuthorship W3193402490A5040956118 @default.
• W3193402490 hasAuthorship W3193402490A5050059268 @default.
• W3193402490 hasAuthorship W3193402490A5064062758 @default.
• W3193402490 hasAuthorship W3193402490A5066619473 @default.
• W3193402490 hasAuthorship W3193402490A5068572641 @default.
• W3193402490 hasAuthorship W3193402490A5069644796 @default.
• W3193402490 hasAuthorship W3193402490A5089855305 @default.

• next